SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 525.69 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 1,224.27 |
| Book Value / Share | 4.61 |
| Price / Book | n/a |
| NCAV ($M) | 278.61 |
| NCAV / Share | 1.05 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.08 |
| Return on Assets (ROA) | -0.07 |
| Return on Equity (ROE) | -0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.16 |
| Current Ratio | 5.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 497.41 |
| Assets | 1,443.08 |
| Liabilities | 218.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 421,653 | 2,523,742 | 16.71 | |
| 349,635 | 2,958,722 | 11.82 | |
| 101,176 | 717,505 | 14.10 | |
| 220,093 | 1,563,734 | 14.07 | |
| 178,875 | 1,311,392 | 13.64 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SLGL – Sol-Gel Technologies Ltd. | SLRX – Salarius Pharmaceuticals, Inc. |
| SLS – SELLAS Life Sciences Group, Inc. | SNGX – Soligenix, Inc. |
| SNPX – Synaptogenix, Inc. |
Financial data and stock pages provided by
Fintel.io